These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 16885335)
1. Divergent routes to oral cancer. Hunter KD; Thurlow JK; Fleming J; Drake PJ; Vass JK; Kalna G; Higham DJ; Herzyk P; Macdonald DG; Parkinson EK; Harrison PR Cancer Res; 2006 Aug; 66(15):7405-13. PubMed ID: 16885335 [TBL] [Abstract][Full Text] [Related]
2. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine. McGregor F; Muntoni A; Fleming J; Brown J; Felix DH; MacDonald DG; Parkinson EK; Harrison PR Cancer Res; 2002 Aug; 62(16):4757-66. PubMed ID: 12183435 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. Gasco M; Bell AK; Heath V; Sullivan A; Smith P; Hiller L; Yulug I; Numico G; Merlano M; Farrell PJ; Tavassoli M; Gusterson B; Crook T Cancer Res; 2002 Apr; 62(7):2072-6. PubMed ID: 11929827 [TBL] [Abstract][Full Text] [Related]
4. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma. Banerjee AG; Bhattacharyya I; Lydiatt WM; Vishwanatha JK Cancer Res; 2003 Nov; 63(22):7769-76. PubMed ID: 14633702 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer. Jordan RC; Macabeo-Ong M; Shiboski CH; Dekker N; Ginzinger DG; Wong DT; Schmidt BL Clin Cancer Res; 2004 Oct; 10(19):6460-5. PubMed ID: 15475433 [TBL] [Abstract][Full Text] [Related]
6. Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas. Shahnavaz SA; Bradley G; Regezi JA; Thakker N; Gao L; Hogg D; Jordan RC Cancer Res; 2001 Mar; 61(6):2371-5. PubMed ID: 11289098 [TBL] [Abstract][Full Text] [Related]
8. Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Shibata M; Kodani I; Osaki M; Araki K; Adachi H; Ryoke K; Ito H Oral Oncol; 2005 Mar; 41(3):304-12. PubMed ID: 15743693 [TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression. Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295 [TBL] [Abstract][Full Text] [Related]
10. P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals. Blokx WA; de Jong EM; de Wilde PC; Bulten J; Link MM; Ruiter DJ; van de Kerkhof PC Mod Pathol; 2003 Sep; 16(9):869-78. PubMed ID: 13679450 [TBL] [Abstract][Full Text] [Related]
11. Runt-related transcription factor 3 expression in human oral squamous cell carcinomas; implication for tumor progression and prognosis. Tanji Y; Osaki M; Nagahama Y; Kodani I; Ryoke K; Ito H Oral Oncol; 2007 Jan; 43(1):88-94. PubMed ID: 16798064 [TBL] [Abstract][Full Text] [Related]
12. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings. Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865 [TBL] [Abstract][Full Text] [Related]
13. Expression of epiregulin, a novel epidermal growth factor ligand associated with prognosis in human oral squamous cell carcinomas. Shigeishi H; Higashikawa K; Hiraoka M; Fujimoto S; Mitani Y; Ohta K; Takechi M; Kamata N Oncol Rep; 2008 Jun; 19(6):1557-64. PubMed ID: 18497965 [TBL] [Abstract][Full Text] [Related]
14. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250 [TBL] [Abstract][Full Text] [Related]
15. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis. Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779 [TBL] [Abstract][Full Text] [Related]
16. A molecular study of desmosomes identifies a desmoglein isoform switch in head and neck squamous cell carcinoma. Teh MT; Parkinson EK; Thurlow JK; Liu F; Fortune F; Wan H J Oral Pathol Med; 2011 Jan; 40(1):67-76. PubMed ID: 20923451 [TBL] [Abstract][Full Text] [Related]
17. Disease mechanism and biomarkers of oral squamous cell carcinoma. Brinkman BM; Wong DT Curr Opin Oncol; 2006 May; 18(3):228-33. PubMed ID: 16552233 [TBL] [Abstract][Full Text] [Related]
18. MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis. Sawhney M; Rohatgi N; Kaur J; Gupta SD; Deo SV; Shukla NK; Ralhan R Oral Oncol; 2007 May; 43(5):515-22. PubMed ID: 16996781 [TBL] [Abstract][Full Text] [Related]
19. Is p16(INK4a) protein expression in oral ST lesions a reliable precancerous marker? Greer RO; Meyers A; Said SM; Shroyer KR Int J Oral Maxillofac Surg; 2008 Sep; 37(9):840-6. PubMed ID: 18606525 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma. Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]